Statistics for Bristol-Myers Squibb (id:8499 BMY)
Valuation metrics
Market cap
115.11B
Enterprise value
157.59B
Trailing P/E (ttm)
11.54
Forward P/E
8.07
PEG ratio
8.07
Price/Sales (ttm)
2.43
Price/Book (mrq)
6.71
Enterprise Value/Revenue
3.32
Enterprise Value/EBITDA
8.22
Overview
Shares outstanding
2.03B
Float
2.02B
Shares short
25.60M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
10.51M
Average volume (90 days)
Price summary
52-Week low
39.35
52-Week high
61.08
52-Week change
10.26%
Beta
3.00
50-Day moving average
56.03
200-Day moving average
49.20
Dividends and splits
Forward annual dividend rate
2.40
Forward annual dividend yield
5.00
Trailing annual dividend rate
2.40%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
3.43
Payout ratio
3.00
Dividend date
February 3, 2025
Ex-dividend date
January 3, 2025
Last split factor
2:1
Last split date
August 7, 2001
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-15.30%
Operating margin
18.48%
Operational effectiveness
Return on assets
6.07%
Return on equity
-31.33%
Income statement
Revenue (ttm)
23.41
Revenue per share (ttm)
23.41
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
34.31B
EBITDA
18.41B
Net income to common (ttm)
-7,257,999,872.00
Diluted EPS (ttm)
-3.58
Quarterly earnings growth (yoy)
-37.20%
Balance sheet
Total cash (mrq)
8.09B
Total cash per share (mrq)
3.99
Total debt (mrq)
51.44B
Total Debt/Equity (mrq)
299.05
Current ratio (mrq)
124.00%
Book value per share (mrq)
8.45
Cash flow
Cash flow statement
15.00B
Levered free cash flow (LFCF)
17.52B